HIGHLIGHTS
- who: Sophie Chatterton from the Children`s Hospital of Orange County, United States University of Colorado Anschutz Medical have published the paper: Case series: Immune checkpoint inhibitor-induced transverse myelitis, in the Journal: Neurology, Nepean Hospital, Sydney, NSW, Australia, 3 Faculty of Medicine, University of Sydney, Sydney,
- what: The authors propose that prompt intensive immunomodulation is favored for patients with ICI-transverse myelitis in an attempt to reduce associated significant morbidity and mortality. The study demonstrates the significant risk of relapse of ICI-induced transverse myelitis following cessation of immunomodulation. The authors propose one treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.